Bridge to transplantation with a Thoratec left ventricular assist device in a 17-kg child

Area of Science:

• Pediatric cardiology
• Mechanical circulatory support
• Cardiomyopathy research

Background:

• Viral cardiomyopathy presents a critical challenge in pediatric heart failure.
• Left ventricular assist devices (LVADs) offer a potential bridge to transplantation.
• Limited data exists on LVAD use in very young and small pediatric patients.

Observation:

• A 7-year-old, 17-kg boy with viral cardiomyopathy received a Thoratec LVAD.
• The device provided circulatory support for 23 days prior to heart transplantation.
• The patient experienced a stroke during the LVAD support period.

Findings:

• The patient survived heart transplantation and remains alive over one year post-procedure.
• Functional recovery is notable, with residual spastic paresis in the left hand.
• This case represents the youngest and smallest patient successfully supported by this specific LVAD model.

Implications:

• Successful LVAD application in a very small pediatric patient expands the potential use of mechanical circulatory support.
• The study highlights the feasibility of using the Thoratec LVAD in pediatric populations.
• Further research into specialized techniques for pediatric LVAD implantation and management is warranted.